To explore this possibility, phase II
Cilomilast clinical trial combination studies of tegobuvir plus GS-9256 with Peg-IFN and RBV are under way. The authors thank the patients for their participation in this study. The authors are also grateful to Caroline Lascoux-Combe, M.D., Hospital Saint-Louis (Paris, France) for her participation as an investigator. Alex McKenzie and Kevin V. Shianna, Ph.D., of the Duke Center for Human Genome Variation (Durham, NC), ran the Taqman assay on the IL28B SNP. Jennifer King, Ph.D., assisted in the preparation of the manuscript for this article. Additional Supporting Information may be found in the online version of this article. “
“Increased resistance of Helicobacter pylori to antibiotics has increased the need to develop new first-line treatments for H. pylori. We have prospectively evaluated 10-day sequential versus conventional triple therapy in peptic ulcer patients. One hundred and fifty-nine patients with peptic ulcer diseases were prospectively randomized to receive 10 days of lansoprazole, amoxicillin, and clarithromycin
(conventional triple therapy) or 5 days of lansoprazole and amoxicillin followed by 5 days of lansoprazole, clarithromycin, and metronidazole (sequential therapy). Post-treatment H. pylori status was determined by the 13C-urea breath test. Eradication rates, antibiotic resistance rates by agar dilution method, drug compliance, and side-effects were compared. GW 572016 The intention-to-treat eradication rates were 75.9% (95% CI 66.5–85.3%, 60/79) in the sequential therapy group and 58.7% (95% CI 47.9–69.5%, 47/80) in the conventional triple therapy group (P = 0.01), while the per-protocol eradication rates were 86.8% (95% CI 78.7–94.8%, 59/68) and 67.6% (95% CI 56.5–78.7%, 46/68) (P = 0.01), respectively. Compliance and side-effects were similar in the two groups. Culture of
H. pylori showed that 18.2% were resistant to clarithromycin, 41.9% to metronidazole. Dual resistance to both antibiotics was 9.6%. Although 10-day sequential therapy yielded a higher H. pylori eradication rate than 10-day selleckchem conventional triple therapy, the sequential therapy protocol did not result in a sufficiently satisfactory eradication rate. This might be related to the higher antibiotics resistance rate especially to dual resistance. More effective regimens are needed to overcome antibiotic resistance in Korea. “
“Lazo M, Hernaez R, Bonekamp S, Kamel IR, Brancati FL, Guallar E, et al. Non-alcoholic fatty liver disease and mortality among US adults: prospective cohort study. BMJ 2011;343:d6891. (Reprinted with permission.) OBJECTIVE: To evaluate the association between non-alcoholic fatty liver disease and all cause and cause specific mortality in a representative sample of the US general population. DESIGN: Prospective cohort study. SETTING: US Third National Health and Nutrition Examination Survey (NHANES III: 1988-94) with follow-up of mortality to 2006.